Human Chorionic Gonadotropin — Dosing & Research | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Human Chorionic Gonadotropin (hCG)

Also known as: hCG, HCG, β-hCG, beta-hCG, Chorionic Gonadotropin, hyperglycosylated hCG, hCG-H, hCGβ, free beta-subunit hCG, β-core fragment hCG, bcf-hCG, urinary hCG, u-hCG, recombinant hCG, r-hCG, Ovidrel, Pregnyl

Glycoprotein hormone / Gonadotropin

Research chemicalLast updated: October 31, 2026Based on 33 peer-reviewed studies

What it is

Human Chorionic Gonadotropin (hCG) is a hormone used in fertility treatment to trigger ovulation and support early pregnancy. It works by mimicking LH, the hormone that tells the ovaries to release an egg and maintain progesterone levels. Approved for fertility use in many countries; banned by WADA in male athletes.

The scientific side

hCG is a heterodimeric glycoprotein hormone composed of an α-subunit (shared with LH, FSH, TSH) and a unique β-subunit, encoded by the CGB gene cluster. It exists in at least five common molecular forms including regular hCG, sulfated hCG, hyperglycosylated hCG (hCG-H), free hCGβ, and hyperglycosylated free hCGβ. Regular hCG, produced by differentiated syncytiotrophoblast cells, acts as an agonist at the LH/hCG receptor (LHCGR), stimulating progesterone production by corpus luteum cells, maintaining uterine spiral arteries and myometrial quiescence, and supporting early pregnancy (PMID 25707740, PMID 29509368, PMID 19817556). hCG-H, produced by undifferentiated cytotrophoblast cells, is the predominant isoform in the first 2–3 weeks of pregnancy (comprising up to 90% of total hCG) and promotes trophoblast invasion; it activates LHCGR with lower potency than regular hCG and has been reported to act via TGF-β receptor 2 rather than exclusively via LHCGR, though this TGFβR activation has been questioned when highly purified hCG preparations are used. hCG has immunomodulatory properties including modulation of uterine NK cells, Treg cells, and B cells to promote maternal immune tolerance. hCG also stimulates angiogenesis and vasculogenesis via LHCGR expressed on uterine spiral artery mural cells and by inducing VEGF secretion. The free hCGβ subunit and hyperglycosylated free hCGβ function as autocrine growth factors promoting invasion and malignancy in trophoblastic and non-trophoblastic cancers (PMID 22455390, PMID 20654692).

Class: Glycoprotein hormone / Gonadotropin

Administration & storage

Administration
Intrauterine (intracavity) administration via embryo transfer catheter — used in RCTs of IC-hCG for subfertile women (PMID: 30341915)Intrauterine injection in mouse uterus — ex vivo experimental model (PMID: 40869294)Standard injectable administration for ovulation triggering in IVF (route not further specified in abstracts) (PMID: 41239008)Standard injectable administration in bovine/porcine animal studies (route not further specified) (PMID: 40273828PMID: 26130853)
Storage
No abstracts in the reviewed literature explicitly describe storage conditions for therapeutic hCG preparations. Commercial preparations mentioned include urinary hCG (Pregnyl) and recombinant hCG (Ovitrelle/Ovidrel) (PMID: 30287399, PMID: 41239008), but storage conditions are not stated.
Cautions
Ovarian hyperstimulation syndrome (OHSS) is a known risk associated with hCG trigger use in IVF; dual hCG/GnRH agonist trigger protocols were developed in part to reduce OHSS risk.,Commercial hCG preparations (urinary-derived) have been found to contain significant amounts of contaminating growth factors including EGF and TGF-β1, which may cause spurious biological effects in research settings and potentially in clinical preparations; highly purified hCG preparations are recommended for biological studies.,Dose-dependent follicular cyst development was observed in gilts receiving supplemental hCG after standard eCG/hCG treatment; higher doses (200 IU additional) increased cyst frequency significantly.,Elevated hCG levels can be caused by assay interference (heterophilic antibodies, rheumatoid factor, biotin, passive transfer from plasma products) leading to false-positive results and potentially harmful clinical decisions; careful investigation of the source of elevation is essential before initiating treatment (PMID: 39661999, PMID: 31010310, PMID: 29588177).,Sterile technique is required for all injectable and intrauterine administrations to prevent infection.

Legal & regulatory status

US FDA

Not stated in reviewed literature — requires manual verification. Note: PMID 19817556 states that the US FDA considers only regular (intact heterodimeric) hCG as part of a pregnancy test for regulatory purposes, but…

WADA

PMID 24275190 states that hCG is determined for doping control in males, but the specific WADA prohibited list status is not explicitly stated in the reviewed literature — requires manual verification.

Health Canada

Not stated in reviewed literature — requires manual verification.